These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cladosporium spp. as a causative agent of white superficial onychomycosis. Hafidh RR, Abdulamir AS. East Mediterr Health J; 2008; 14(1):231-3. PubMed ID: 18557473 [No Abstract] [Full Text] [Related]
23. Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment. Ranawaka RR, de Silva SH. Int J Dermatol; 2017 Feb; 56(2):202-208. PubMed ID: 27813064 [Abstract] [Full Text] [Related]
25. A new classification of onychomycosis. Baran R, Hay RJ, Tosti A, Haneke E. Br J Dermatol; 1998 Oct; 139(4):567-71. PubMed ID: 9892897 [Abstract] [Full Text] [Related]
26. Onychomycosis due to a fungus of the Aspergillus versicolor group. Torres-Rodriguez JM, Balaguer-Meler J, Martinez AT, Antonell-Reixach J. Mycoses; 1988 Nov; 31(11):579-83. PubMed ID: 2975352 [No Abstract] [Full Text] [Related]
31. Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections. Aspiroz C, Fortuño-Cebamanos B, Rezusta A, Gilaberte Y. Actas Dermosifiliogr; 2013 Oct; 104(8):725-7. PubMed ID: 24067255 [No Abstract] [Full Text] [Related]
32. Mycology of nail disorders. Midgley G, Moore MK, Cook JC, Phan QG. J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S68-74. PubMed ID: 8077512 [Abstract] [Full Text] [Related]
35. Onychomycosis in a special patient population: focus on the diabetic. Rich P, Hare A. Int J Dermatol; 1999 Sep; 38 Suppl 2():17-9. PubMed ID: 10515525 [No Abstract] [Full Text] [Related]